Correlation Between Grupo Televisa and Rapport Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Grupo Televisa and Rapport Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Grupo Televisa and Rapport Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Grupo Televisa SAB and Rapport Therapeutics, Common, you can compare the effects of market volatilities on Grupo Televisa and Rapport Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Grupo Televisa with a short position of Rapport Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Grupo Televisa and Rapport Therapeutics,.
Diversification Opportunities for Grupo Televisa and Rapport Therapeutics,
0.26 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Grupo and Rapport is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding Grupo Televisa SAB and Rapport Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rapport Therapeutics, and Grupo Televisa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Grupo Televisa SAB are associated (or correlated) with Rapport Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rapport Therapeutics, has no effect on the direction of Grupo Televisa i.e., Grupo Televisa and Rapport Therapeutics, go up and down completely randomly.
Pair Corralation between Grupo Televisa and Rapport Therapeutics,
Allowing for the 90-day total investment horizon Grupo Televisa SAB is expected to under-perform the Rapport Therapeutics,. But the stock apears to be less risky and, when comparing its historical volatility, Grupo Televisa SAB is 1.95 times less risky than Rapport Therapeutics,. The stock trades about -0.03 of its potential returns per unit of risk. The Rapport Therapeutics, Common is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 2,080 in Rapport Therapeutics, Common on September 4, 2024 and sell it today you would earn a total of 320.00 from holding Rapport Therapeutics, Common or generate 15.38% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 25.05% |
| Values | Daily Returns |
Grupo Televisa SAB vs. Rapport Therapeutics, Common
Performance |
| Timeline |
| Grupo Televisa SAB |
| Rapport Therapeutics, |
Grupo Televisa and Rapport Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Grupo Televisa and Rapport Therapeutics,
The main advantage of trading using opposite Grupo Televisa and Rapport Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Grupo Televisa position performs unexpectedly, Rapport Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rapport Therapeutics, will offset losses from the drop in Rapport Therapeutics,'s long position.| Grupo Televisa vs. Liberty Global PLC | Grupo Televisa vs. Liberty Global PLC | Grupo Televisa vs. Shenandoah Telecommunications Co | Grupo Televisa vs. Liberty Global PLC |
| Rapport Therapeutics, vs. Cars Inc | Rapport Therapeutics, vs. Amkor Technology | Rapport Therapeutics, vs. Wabash National | Rapport Therapeutics, vs. Marine Products |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Complementary Tools
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |